Opiant Pharmaceuticals Inc. (OPNT)

14.38
NASDAQ : Health Technology
Prev Close 14.53
Day Low/High 14.14 / 14.67
52 Wk Low/High 9.98 / 29.55
Avg Volume 21.70K
Exchange NASDAQ
Shares Outstanding 4.04M
Market Cap 58.72M
EPS -7.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Opiant Pharmaceuticals To Report Second Quarter 2019 Financial Results And Host Conference Call And Webcast On Thursday, August 8

Opiant Pharmaceuticals To Report Second Quarter 2019 Financial Results And Host Conference Call And Webcast On Thursday, August 8

SANTA MONICA, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals Expands Partnership With Sanofi, Signs Agreement For Manufacturing OPNT004 For Treatment Of Acute Cannabinoid Overdose

Opiant Pharmaceuticals Expands Partnership With Sanofi, Signs Agreement For Manufacturing OPNT004 For Treatment Of Acute Cannabinoid Overdose

SANTA MONICA, Calif., July 23, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc.

A Medical Device Maker, a Real Estate Giant and Other Stocks That Look Good Short

BSX, SOHU, BPY, IRM and OPNT all recently were downgraded by TheStreet's Quant Ratings.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CTHR, MOMO, SMIT, SPKE, TESS Downgrades: DCO, HTA, IMH, OPNT Initiations: TRXC Read on to get TheStreet Quant Ratings' detailed report:

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANF, CWCO, DOOR, GCP, OSN, PLT, SJT, TRC Downgrades: FNGN, OPNT, ZBH Initiations: CSTR, DRNA, MPO, MRT Read on to get TheStreet Quant Ratings' detailed report:

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AHGP, BHB, CTRN, DENN, DM, EHTH, HPE, HRTG, IEC, OPNT Downgrades: KEP, WGP Initiations: NBLX, VLRX Read on to get TheStreet Quant Ratings' detailed report:

The 6 Medications Being Used to Tackle the Opioid Epidemic

The 6 Medications Being Used to Tackle the Opioid Epidemic

The U.S. opioid crisis rages on. TheStreet takes a look at several drugs being used to help treat people.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: FUNC, HAIN, PRCP, SHEN, SSNT Downgrades: AVAV, CLDT, PAG, TLF, TOWR Initiations: OPNT, TLND Read on to get TheStreet Quant Ratings' detailed report:

Opiant Pharmaceuticals, Inc. Announces Additional $3.75 Million Payment From NARCAN® Nasal Spray Royalty Monetization

Opiant Pharmaceuticals, Inc. Announces Additional $3.75 Million Payment From NARCAN® Nasal Spray Royalty Monetization

Company Received Additional Payment From SWK Funding LLC Based on Achievement of $25 Million Net Sales of NARCAN® Nasal Spray Milestone

Opiant Pharmaceuticals, Inc. Announces FDA Orange Book Listing For New NARCAN® Nasal Spray Patent

Opiant Pharmaceuticals, Inc. Announces FDA Orange Book Listing For New NARCAN® Nasal Spray Patent

Listing Strengthens IP Position and Enhances NARCAN Product Exclusivity

TheStreet Quant Rating: D (Sell)